Economic outcomes in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate plus prednisone

Abstract Authors: Krishnan Ramaswamy, Stanislav Lechpammer, Jack Mardekian, Ahong Huang, Neil M Schultz, Rickard Sandin, Li Wang, Onur Baser, Daniel J George Introduction: Prostate cancer (PC) is the second leading cause of cancer death among US men and accounts for...

Health outcomes among patients diagnosed with schizophrenia in the US Veterans Health Administration population who transitioned from once-monthly to once-every-3-month paliperidone palmitate: An observational retrospective analysis

Abstract Authors: Charmi Patel, Antoine El Khoury, Ahong Huang, Li Wang, Onur Baser, Kruti Joshi Introduction: There is limited literature on treatment patterns, healthcare resource utilization (HRU), and costs among patients who transition from once-monthly...

Treatment patterns, healthcare resource utilization and costs among schizophrenia patients treated with long‐acting injectable vs oral antipsychotics

Abstract Authors: Shah A, Xie L, Kariburyo F, Zhang Q, Gore M Introduction: Long-acting injectable (LAI) antipsychotic use may reduce healthcare resource utilization compared with oral antipsychotic use by improving adherence and reducing dosing frequency. Our goal...

Hypoglycemia after initiation of basal insulin in patients with type 2 diabetes in the United States: Implications for treatment discontinuation and healthcare costs and utilization

Abstract Authors: Dalal MR, Kazemi M, Ye F, Xie L. Introduction: Hypoglycemia and fear of hypoglycemia may contribute to basal insulin discontinuation, poor glycemic control, and increased healthcare burden in patients with type 2 diabetes (T2D). This study aimed...